...Done!
Skip to main content
🔍 See what insiders are buying — free 7-day trial, no credit card required. Get started →
LH NYSE 🇺🇸 US
Labcorp
Healthcare
Not a Dip
Price Zone: Consider Trimming
🔒 Full AI Analysis — Pro
23Score
DipBuster Score™
$329.93 +$6.18 (+1.91%) Live price · Source: Yahoo
52-Week Position
$244.52 88% of range $341.80
Dividend
—
no income
Mkt Cap
N/A
total value
Mkt CapN/A
P/EN/A
DividendNone
BetaN/A
52W High$341.80
52W Low$244.52
DipBuster Brief Key signals at a glance
Zone: Consider Trimming
Bearish
Near 52-Week High — Asymmetric Risk
At 88% of its annual range the stock is close to its peak. New buyers face limited upside and meaningful downside if sentiment shifts.
Neutral
Earnings Data Unavailable
P/E ratio could not be determined — this is common for early-stage, loss-making, or recently-listed companies.
Valuation
P/E Ratio—
Mkt CapN/A
52W Position88% of range
EV/EBITDA—
Cash Flow
FCF Yield—
FCF / Share—
Op. Cash Flow—
Margins
Gross Margin—
Op. Margin—
Net Margin—
Balance Sheet
Cash—
Total Debt—
Net Cash—
Dividend
Yield—
Annual / shNone
Beta—
🔒 FCF, margins & balance sheet data are hidden — create a free account to see them.
Charts

Recent director dealings and insider transactions at Labcorp (LH), from SEC Form 4 filings. Open-market buys by directors spending their own money are one of the strongest signals in investing.

Date Insider Type Shares
2026-09-01 Vaughn Bryan T BUY 1,500
2026-09-01 Meltzer Jonathan C BUY 900
2026-09-01 Oyegunwa Akinbolade BUY 750
2026-09-01 Caveney Brian J BUY 3,000
2026-08-17 Anderson Kerrii B SELL 3,000
2026-08-11 Schechter Adam H SELL 4,669
2026-08-04 Summy Amy B. SELL 924
2026-08-03 Wilkinson Peter J SELL 1,338
2026-08-03 Wilkinson Peter J SELL 1,338
2026-08-03 Wilkinson Peter J BUY 1,338

Valuation

P/E RatioN/A
Market CapN/A
BetaN/A
Dividend/yrNone
52W High$341.80
52W Low$244.52

52-Week Range

$244.52Now$341.80
88% through annual range
From 52W High−3.5%
From 52W Low+34.9%
📖 Plain English Summary
Labcorp is at 88% of its 52-week range.

🏦 Analyst Price Target

Loading…

🎯 Analyst Revenue & EPS Estimates

Loading estimates…

🔄 Peer Comparison

Loading peers…
Loading dividend data…
Latest news for LH 🟢 Bullish ⬜ Neutral 🔴 Bearish
🤖
DipBuster AI Analysis — LH
Heuristic · balance sheet, insider filings, price data, academic research

Labcorp — DipBuster Score 23/100

Graham value assessment, NCAV analysis, price zones...

Insider signals, cluster detection, risk factors...

🔒
Full AI Analysis — Pro
Price zones, Graham analysis, insider signals
Upgrade →

Track Labcorp free

Add LH to a watchlist, set insider-buy and price alerts, and get the full financial picture — free account, no card.

Sponsored · FCA Regulated Broker
Trading 212
Commission-free investing. ISA and GIA available. FCA regulated.
Free share worth up to £100 when you sign up
Open Free Account →
Capital at risk. Your investments can go down as well as up. Disclaimer
DipBuster Score™ Breakdown
Value & P/E 0/30
Dip Position 5/25
Momentum & Volume 13/25
Quality & Size 5/10
Insider Activity 0/10
🎯 Dip Buyer Signal
1 /100 · NEUTRAL
dip depth 1/25
oversold rsi 0/25
mean reversion 0/15
insider zone 0/25
capitulation 0/10
Technical signal only. Not financial advice.
Quick Take
⚪
Not a Dip
DipBuster Score: 23/100
📈 Strong recent momentum — price and volume trending in the right direction.

More Healthcare stocks

UNH UnitedHealth GroupJNJ Johnson & JohnsonABT Abbott LaboratoriesTMO Thermo Fisher ScientificDHR Danaher Corp.MDT Medtronic plcSYK Stryker Corp.BSX Boston ScientificAll Healthcare stocks →